EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preserving Laryngo‐Esophageal Function in Patients With Hypopharyngeal Cancer Treated With Radiotherapy: Predictive Factors and Long‐Term Outcomes

Aya Nakajima iD, Michio Yoshimura iD, Shinya Hiraoka, Ryota Nakashima, Yo Kishimoto, Koichi Omori iD, Takashi Mizowaki iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Aya Nakajima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Hypopharyngeal Neoplasms, Radiotherapy, Intensity-Modulated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Functional outcomes after hypopharyngeal cancer (HPC) treatment have a significant effect on patients' quality of life and prognosis. This study aimed to identify the predictive factors associated with laryngo‐esophageal dysfunction in patients with HPC who received definitive radiotherapy.

Methods

Patients with HPC treated with definitive intensity‐modulated radiotherapy between 2007 and 2019 at our institution were retrospectively evaluated. Laryngo‐esophageal dysfunction‐free survival (LDFS) events were defined as local recurrence, laryngo‐esophageal dysfunction (defined as tracheostomy or feeding tube dependence), or death from any cause.

Results

The median follow‐up period was 61 months for the 80 patients included in the study. The 5‐year LDFS rate was 47%. A clinical T4 stage and lower pretreatment prognostic nutritional index (PNI) were independently associated with a lower LDFS.

Conclusion

A clinical T4 stage and lower pretreatment PNI were identified as predictors of a lower LDFS after definitive radiotherapy for HPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypopharyngeal NeoplasmsRadiotherapy, Intensity-ModulatedHumansMaleFemaleMiddle AgedAgedRetrospective StudiesPrognosisNeoplasm StagingAdultAged, 80 and overTreatment OutcomeQuality of LifeLarynxNutrition AssessmentEsophagusNeoplasm Recurrence, LocalFollow-Up Studies

Stichwörter der Autor:innen

hypopharyngeal cancerintensity‐modulated radiotherapylaryngo‐esophageal dysfunction‐free survivalpredictive factorsprognostic nutritional index

Autor:innen und Institutionen

  • Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

ORCID-Profile: Aya Nakajima, Michio Yoshimura, Koichi Omori, Takashi Mizowaki

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Nakajima, A., Yoshimura, M., Hiraoka, S., Nakashima, R., Kishimoto, Y., Omori, K., & Mizowaki, T. (2024). Preserving Laryngo‐Esophageal Function in Patients With Hypopharyngeal Cancer Treated With Radiotherapy: Predictive Factors and Long‐Term Outcomes. Cancer Medicine. https://doi.org/10.1002/cam4.70374

Vancouver

Nakajima A, Yoshimura M, Hiraoka S, Nakashima R, Kishimoto Y, Omori K, et al. Preserving Laryngo‐Esophageal Function in Patients With Hypopharyngeal Cancer Treated With Radiotherapy: Predictive Factors and Long‐Term Outcomes. Cancer Medicine. 2024. doi:10.1002/cam4.70374

BibTeX
@article{Nakajima2024,
  author = {Nakajima, Aya and Yoshimura, Michio and Hiraoka, Shinya and Nakashima, Ryota and Kishimoto, Yo and Omori, Koichi and Mizowaki, Takashi},
  title = {Preserving Laryngo‐Esophageal Function in Patients With Hypopharyngeal Cancer Treated With Radiotherapy: Predictive Factors and Long‐Term Outcomes},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70374}
}
Kostenlos starten →